Literature DB >> 26926650

Susceptibility Testing of Antibiotics That Degrade Faster than the Doubling Time of Slow-Growing Mycobacteria: Ertapenem Sterilizing Effect versus Mycobacterium tuberculosis.

Shashikant Srivastava1, Sander P van Rijn2, A Mireille A Wessels2, Jan-Willem C Alffenaar3, Tawanda Gumbo1.   

Abstract

Drug susceptibility tests (DSTs) for Mycobacterium tuberculosis require at least 7 days of incubation. Drugs that are unstable at 37°C, such as ertapenem, are likely to be degraded before killing or inhibiting slow-growing bacteria. This would alter the MICs of these drugs, including ertapenem, leading to falsely high MICs. Here, we describe a new strategy we developed to perform DSTs and measure MICs for such unstable compounds.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26926650      PMCID: PMC4862539          DOI: 10.1128/AAC.02924-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience.

Authors:  Simon Tiberi; Lia D'Ambrosio; Saverio De Lorenzo; Pietro Viggiani; Rosella Centis; Giovanni Sotgiu; Jan Wilem C Alffenaar; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2015-11-19       Impact factor: 16.671

2.  Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs.

Authors:  Tawanda Gumbo; Chandima S W Siyambalapitiyage Dona; Claudia Meek; Richard Leff
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

3.  Basic mechanisms of chemotherapy.

Authors:  D A Mitchison
Journal:  Chest       Date:  1979-12       Impact factor: 9.410

4.  Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.

Authors:  Saverio De Lorenzo; Jan Wilem Alffenaar; Giovanni Sotgiu; Rosella Centis; Lia D'Ambrosio; Simon Tiberi; Mathieu S Bolhuis; Richard van Altena; Piero Viggiani; Andrea Piana; Antonio Spanevello; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2012-09-20       Impact factor: 16.671

Review 5.  Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis.

Authors:  Keertan Dheda; Tawanda Gumbo; Neel R Gandhi; Megan Murray; Grant Theron; Zarir Udwadia; G B Migliori; Robin Warren
Journal:  Lancet Respir Med       Date:  2014-03-24       Impact factor: 30.700

6.  Activity of carbapenems combined with clavulanate against murine tuberculosis.

Authors:  Nicolas Veziris; Chantal Truffot; Jean-Luc Mainardi; Vincent Jarlier
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

7.  Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.

Authors:  Sandirai Musuka; Shashikant Srivastava; Chandima Wasana Siyambalapitiyage Dona; Claudia Meek; Richard Leff; Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

8.  In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and inactivation of these enzymes by carbapenems.

Authors:  Mathilde Cordillot; Vincent Dubée; Sébastien Triboulet; Lionel Dubost; Arul Marie; Jean-Emmanuel Hugonnet; Michel Arthur; Jean-Luc Mainardi
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

9.  Quantification and validation of ertapenem using a liquid chromatography-tandem mass spectrometry method.

Authors:  S P van Rijn; A M A Wessels; B Greijdanus; D J Touw; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

Review 10.  Bacterial growth and cell division: a mycobacterial perspective.

Authors:  Erik C Hett; Eric J Rubin
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 11.056

View more
  13 in total

1.  Pharmacokinetics of 2,000 Milligram Ertapenem in Tuberculosis Patients.

Authors:  M A Zuur; S Ghimire; M S Bolhuis; A M A Wessels; R van Altena; W C M de Lange; J G W Kosterink; D J Touw; T S van der Werf; O W Akkerman; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

2.  Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing.

Authors:  Sander P van Rijn; Shashikant Srivastava; Mireille A Wessels; Dick van Soolingen; Jan-Willem C Alffenaar; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant Tuberculosis.

Authors:  S P van Rijn; M A Zuur; R van Altena; O W Akkerman; J H Proost; W C M de Lange; H A M Kerstjens; D J Touw; T S van der Werf; J G W Kosterink; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

4.  Evaluation of Carbapenems for Treatment of Multi- and Extensively Drug-Resistant Mycobacterium tuberculosis.

Authors:  Sander P van Rijn; Marlanka A Zuur; Richard Anthony; Bob Wilffert; Richard van Altena; Onno W Akkerman; Wiel C M de Lange; Tjip S van der Werf; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 5.  Pharmacologic management of Mycobacterium ulcerans infection.

Authors:  Tjip S Van Der Werf; Yves T Barogui; Paul J Converse; Richard O Phillips; Ymkje Stienstra
Journal:  Expert Rev Clin Pharmacol       Date:  2020-04-20       Impact factor: 4.108

6.  In vitro Degradation of Antimicrobials during Use of Broth Microdilution Method Can Increase the Measured Minimal Inhibitory and Minimal Bactericidal Concentrations.

Authors:  Elodie A Lallemand; Marlène Z Lacroix; Pierre-Louis Toutain; Séverine Boullier; Aude A Ferran; Alain Bousquet-Melou
Journal:  Front Microbiol       Date:  2016-12-21       Impact factor: 5.640

7.  Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis.

Authors:  Devyani Deshpande; Shashikant Srivastava; Paula Bendet; Katherine R Martin; Kayle N Cirrincione; Pooi S Lee; Jotam G Pasipanodya; Keertan Dheda; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 8.  Chemical Classes Presenting Novel Antituberculosis Agents Currently in Different Phases of Drug Development: A 2010-2020 Review.

Authors:  Klaudia T Angula; Lesetja J Legoabe; Richard M Beteck
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-13

9.  Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution.

Authors:  Ximena Gonzalo; Giovanni Satta; Julio Ortiz Canseco; Timothy D McHugh; Francis Drobniewski
Journal:  BMC Microbiol       Date:  2020-08-31       Impact factor: 3.605

10.  Development of a Rapid, Antimicrobial Susceptibility Test for E. coli Based on Low-Cost, Screen-Printed Electrodes.

Authors:  Stuart Hannah; Alexandra Dobrea; Perrine Lasserre; Ewen O Blair; David Alcorn; Paul A Hoskisson; Damion K Corrigan
Journal:  Biosensors (Basel)       Date:  2020-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.